-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Zimmer Biomet Holdings, Lowers Price Target to $100

Benzinga·02/12/2026 15:21:15
Listen to the news
Barclays analyst Matt Miksic maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Underweight and lowers the price target from $104 to $100.